The Social Security Organisation (Perkeso) is exploring the potential for strategic collaboration, particularly with the ...

An update from Lixte Biotechnology Holdings ( ($LIXT) ) is now available. On November 24, 2025, LIXTE Biotechnology Holdings completed the ...

Seoul St. Mary’s Hospital is introducing the "next-generation proton therapy system," often referred to as the "dream cancer treatment device." Currently, only two institutions in South Korea operate ...

Investing.com -- Lixte Biotechnology Holdings Inc. (NASDAQ:LIXT) stock fell 11.5% Tuesday after the company announced it has completed the acquisition of Liora Technologies Europe Ltd., a UK-based ...

Located at the Daresbury site of the renowned UK-based Science and Technology Facilities Council (STFC), with $300+ million ...

Of the total, 42,054 cases or 10.92% were for cancer, says deputy human resources minister Abdul Rahman Mohamad.

Three-year-old Seren has become the 1,000th NHS patient to receive proton beam therapy, after being treated at UHS and General.

A 16-month-old boy is waiting to find out if he can receive lifesaving surgery on the other side of the world after being diagnosed with a rare and aggressive cancer.

Australia's promise of advanced cancer treatment with proton beam therapy remains unfulfilled after a decade. Families, like the Frasers, face emotional and financial burdens, travelling abroad for ...

The mother of a three-year-old girl who was a hospital's 1,000th patient to receive a highly targeted form of radiotherapy ...

The tech is the most advanced form of radiation, delivering a targeted energy beam to tumors while sparing healthy tissue ...